Social Media Buzz 2/12/13

Immune Pharmaceuticals and EpiCept amend merger agreement to allow Immune to purchase up to $0.5 million new EpiCept common stock

KV Pharmaceutical to file quarterly report late

ViroPharma to participate In two upcoming healthcare investor conferences

Click here to subscribe to daily news headlines in your email inbox